AK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62481139653892E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.10462807976364E-15 |
Normal-vs-Stage2 |
1.4682000004651E-07 |
Normal-vs-Stage3 |
1.59872115546023E-14 |
Normal-vs-Stage4 |
1.29130000026123E-07 |
Stage1-vs-Stage2 |
9.114000E-01 |
Stage1-vs-Stage3 |
2.349800E-01 |
Stage1-vs-Stage4 |
4.470000E-01 |
Stage2-vs-Stage3 |
4.959800E-01 |
Stage2-vs-Stage4 |
5.498400E-01 |
Stage3-vs-Stage4 |
1.305250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.99760216648792E-15 |
Normal-vs-AfricanAmerican |
6.65529964472E-10 |
Normal-vs-Asian |
2.1599999999955E-05 |
Caucasian-vs-AfricanAmerican |
5.531900E-02 |
Caucasian-vs-Asian |
2.969200E-01 |
AfricanAmerican-vs-Asian |
8.146000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.22044604925031E-16 |
Normal-vs-Female |
4.19331236400922E-13 |
Male-vs-Female |
2.515200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.27099999999814E-05 |
Normal-vs-Age(41-60Yrs) |
1.56541446472147E-14 |
Normal-vs-Age(61-80Yrs) |
1.0547118733939E-14 |
Normal-vs-Age(81-100Yrs) |
1.66741999999553E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.053000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.322600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.612570E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.168200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.868200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.506200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.433970E-02 |
Normal-vs-Grade 2 |
1.40998324127395E-14 |
Normal-vs-Grade 3 |
2.0371482278847E-12 |
Normal-vs-Grade 4 |
1.0445000420134E-10 |
Grade 1-vs-Grade 2 |
1.538160E-01 |
Grade 1-vs-Grade 3 |
2.586600E-01 |
Grade 1-vs-Grade 4 |
1.093610E-01 |
Grade 2-vs-Grade 3 |
7.987000E-01 |
Grade 2-vs-Grade 4 |
2.158600E-01 |
Grade 3-vs-Grade 4 |
3.384200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.74170000036378E-07 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
1.29896093881143E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.626032641866E-12 |
Normal-vs-N1 |
4.180000E-03 |
N0-vs-N1 |
9.025600E-01 |
|
|